Navigation Links
Racial disparity in colon cancer survival not easily explained, UAB researchers say
Date:11/23/2009

BIRMINGHAM, Ala. A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. The study is published online Nov. 23 in Cancer, a journal of the American Cancer Society.

The finding indicates that although BMI and co-morbidity are independent predictors of poor survival for all patients, these factors do not explain the increased risk of death associated with African-Americans. "Therefore, more research is needed to gain a fuller understanding of how race and ethnicity are involved in colon cancer survival following surgery," says Upender Manne, Ph.D., an associate professor in the UAB Department of Pathology and the lead study author.

For many cancers, including colon cancer, African-Americans have lower survival rates than whites; possible reasons behind this disparity including genetic variation, tumor characteristics, access to health care and other factors are being examined extensively, Manne says. There was a belief that racial disparity in survival following surgery for colon cancer was related to a high BMI and co-morbidity. BMI is a numerical value of weight in relation to height; obesity is defined as a BMI of 30 or more.

The UAB researchers analyzed data from 496 patients who underwent surgery for colon cancer at UAB Hospital between 1981 and 2002. Until the end of the study in 2008, the researchers looked at factors such as BMI, co-morbidity, demographics and tumor properties as they relate to survival rates.

The analysis revealed that African-Americans were 34 percent more likely to have died by the end of the study than Caucasians. Among patients with advanced stages of cancer, being underweight increased the risk of death by 87 percent. Being overweight or obese was protective in patients with Stage IV disease and decreased the risk of death by 42 percent.

"That was the surprising finding for us that a high BMI was actually protective in patients with advanced-stage disease," Manne says. "Co-morbidity in cancer can have an important role, we know, because it impacts everything from the timing of diagnosis to treatment decisions. Obviously, BMI and co-morbidity are not the answers we need to explain the survival disparity in colon cancer. Something else is going on."


'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

Related biology news :

1. Racial disparities in cardiovascular health linked to birth weight, slavery
2. Hypertension disparity linked to environment
3. University of Toronto study shows disparity of effect of climate change on UV radiation
4. Western diet linked to increased risk of colon cancer recurrence
5. Pig study sheds new light on the colonisation of Europe by early farmers
6. Analysis of breast and colon cancer genes finds many areas of differences between tumors
7. Genome update defines landscape of breast and colon cancers
8. $2.7 million awarded for metastatic colon cancer research
9. Colony collapse disorder symposium added to ESA Annual Meeting
10. DNA methylation shown to promote development of colon tumors
11. Vitamin D and calcium influence cell death in the colon, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining ... Chicago. The result of a collaboration among several companies with expertise in toolholding, ...
Breaking Biology Technology: